All articles by Daniel Garrun

  1. Taking aim with nanotechnology

    It’s a dilemma pharmaceutical researchers have been grappling with for decades. How do you ensure a sufficient therapeutic dose of…
    Read More…

    15 Nov
  2. Geron announces shift from stem cell research to oncology

    Geron Corporation has announced that it will discontinue further development of its stem cell programmes to focus on its first-in-class…
    Read More…

    14 Nov
  3. US drug approval rates higher than ever

    Over the past 12 months, the US Food and Drug Administration (FDA) approved 35 new medicines, the second highest approval…
    Read More…

    3 Nov
  4. Keeping your cool: Pharmaceutical supply chain management in remote areas

    South African case study Local distribution partners often have to deal with many of the complications involved in getting pharmaceuticals…
    Read More…

    25 Oct
  5. Teva and Dr Reddy’s pounce with Zyprexa generics

    Generic drug makers Teva Pharmaceutical Industries and Dr Reddy’s Laboratories have announced the commercial launch of olanzapine tablets, a generic…
    Read More…

    25 Oct
  6. EU regulator launches antitrust probe over suspected painkiller delay

    Antitrust regulators from the European Union are investigating a suspected agreement between Johnson & Johnson and Novartis to delay the…
    Read More…

    23 Oct
  7. Carpooling for Cargo

    In 2009, the World Economic Forum’s ‘Supply Chain Decarbonization’ report revealed that 24% of goods vehicle kilometres in the EU…
    Read More…

    19 Oct
  8. Onyx to retain Nexavar rights

    Onyx pharmaceuticals have reached an agreement with Bayer that will see the company retain rights to the cancer drug Nexavar…
    Read More…

    12 Oct
  9. Fire at Orchid pharmaceuticals facility

    A fire at India-based Orchid Chemical and Pharmaceutical’s research centre in Chennai as destroyed lab equipment and computers. The fire,…
    Read More…

    25 Sep
Close
Close
Close

Go Top